Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Multiplex Assays Companies

Multiplex Assays companies are pioneers in advanced diagnostic technologies. Specializing in research, development, and distribution, these organizations provide cutting-edge assays that allow simultaneous analysis of multiple biomarkers, revolutionizing the efficiency and accuracy of diagnostic processes.

Multiplex Assays Market

 


Latest Multiplex Assays Companies Updates:


Luminex Corporation acquired by DiaSorin S.p.A. in a USD 1.8 billion deal: This consolidation strengthens DiaSorin's position in the multiplex assay market, particularly in molecular diagnostics.


Becton, Dickinson and Company (BD) launched its BD COR System: This fully automated system leverages robotics and software to set a new standard in workflow efficiency for infectious disease molecular testing.


InDevR, Inc. launched a VaxArray Pneumococcal Assay kits: This rapid and accurate multiplex assay assesses pneumococcal vaccines at various stages of manufacturing.


Vela Diagnostics launched PathoKey MP UTI ID and AMR PCR Test: This research-use tool offers simultaneous identification and antibiotic susceptibility testing for urinary tract infections.Sentinel Diagnostics launched SentiNat 200 and Stat-Nat SN200 Real-Time PCR assays: This fully automated system and assays enable quantitative detection of 10 viruses common in respiratory infections.


List of Multiplex Assays companies in the market:



  • Thermo Fisher Scientific Inc

  • Illumina Inc

  • Bio-Rad Laboratories Inc

  • Qiagen

  • Abcam plc

  • BD

  • Merck Sharp & Dohme Corp

  • Agilent Technologies

  • Meso Scale Diagnostics LLC

  • Randox Laboratories Ltd


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.